Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Zhefu Zhao"'
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/f9c25c28fee345d48911d2546ffedf7d
Publikováno v:
Molecular Cancer, Vol 16, Iss 1, Pp 1-10 (2017)
Abstract Background Cancer stem cells are suggested to contribute to the extremely poor prognosis of pancreatic ductal adenocarcinoma and dysregulation of symmetric and asymmetric stem cell division may be involved. Anticancer benefits of phytochemic
Externí odkaz:
https://doaj.org/article/806dcaba274a43e59b16ca62cad50b7b
Publikováno v:
Archaeometry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::584d909b48682ec613d0b85ba5c75dc6
https://doi.org/10.1111/arcm.12874
https://doi.org/10.1111/arcm.12874
Autor:
Burkhard Lehner, Ingrid Herr, Jörg Fellenberg, Libo Yin, Heiner Sähr, Georg W. Omlor, Zhefu Zhao
Publikováno v:
Cancer Letters. 409:49-55
Giant cell tumors of bone (GCTB) are generally benign bone tumors associated with expansive osteolytic defects, a high rate of recurrence and potential malignant transformation. We recently observed silencing of miR-127-3p and miR-376a-3p in GCTB and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::591fcf81b857f02eb7ae1fc04d09dc67
https://doi.org/10.1016/j.canlet.2017.08.029
https://doi.org/10.1016/j.canlet.2017.08.029
Autor:
Zhefu Zhao, Nathalie Bauer, Pei Fan, Joerg Fellenberg, Jury Gladkich, Ingrid Herr, Prince Saforo Amponsah
Publikováno v:
Cancer Letters. 388:107-117
Resistance to first-line chemotherapies like gemcitabine contributes to high disease lethality in pancreatic cancer. By microarray and qRT-PCR, we observed significant downregulation of microRNA-210 in gemcitabine-resistant cells. The overexpression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f5516e92b86e7d6ab7f5a8eeb17db00
https://doi.org/10.1016/j.canlet.2016.11.035
https://doi.org/10.1016/j.canlet.2016.11.035
Autor:
Ingrid Herr, Clifford C. Nwaeburu, Natalie Bauer, Zhefu Zhao, Alia Abukiwan, Axel Benner, Jury Gladkich
Publikováno v:
Oncotarget
// Clifford C. Nwaeburu 1 , Natalie Bauer 1 , Zhefu Zhao 1 , Alia Abukiwan 1 , Jury Gladkich 1 , Axel Benner 2 , Ingrid Herr 1 1 Team Molecular OncoSurgery, Section Surgical Research, Department of General, Visceral and Transplantation Surgery, Unive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9be2bc271c2573b92ca92adde87616fe
http://europepmc.org/articles/PMC5295436
http://europepmc.org/articles/PMC5295436
Publikováno v:
Cancer Letters. 371:134-141
Although generally benign, giant cell tumors of bone (GCTB) display an aggressive behavior associated with significant bone destruction and lung metastasis in rare cases. This and the very high recurrence rate observed after surgical resection rangin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bef8b46c780394865006668773276ef
https://doi.org/10.1016/j.canlet.2015.10.039
https://doi.org/10.1016/j.canlet.2015.10.039
Autor:
Li Liu, Ingrid Herr, Jörg Fellenberg, Clifford C. Nwaeburu, Oliver Strobel, Axel Benner, Wolfgang Gross, Jury Gladkich, Zhefu Zhao, Nathalie Bauer, Alia Abukiwan
Publikováno v:
International Journal of Oncology
Glucocorticoids (GCs) such as dexamethasone (DEX) are administered as cancer co‑treatment for palliative purposes due to their pro‑apoptotic effects in lymphoid cancer and limited side effects associated with cancer growth and chemotherapy. Howev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74d3a7d185a5beb2987354c64a4daee0
https://pubmed.ncbi.nlm.nih.gov/30387838
https://pubmed.ncbi.nlm.nih.gov/30387838
Autor:
Ingrid Herr, Li Liu, Thilo Hackert, Zhefu Zhao, Clifford C. Nwaeburu, Carsten Sticht, Libo Yin, Wolfgang Gross, Yefeng Yin, Nathalie Bauer, Jury Gladkich, Oliver Strobel, Norbert Gretz
Publikováno v:
Cancer letters. 426
Pancreatic ductal adenocarcinoma (PDA) has poor therapeutic options. Recent patient studies indicate that cholesterol-lowering statins have anti-tumor capacities. We examined several established and primary PDA and normal cell lines as well as PDA pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31ec5d8e7d5d0d8b0656510a29833cf3
https://pubmed.ncbi.nlm.nih.gov/29627496
https://pubmed.ncbi.nlm.nih.gov/29627496